Squarepoint
ODT

Squarepoint’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Squarepoint’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,168
Closed -$214K – 3829
2020
Q4 		$214K Buy
+11,168
New +$172K ﹤0.01% 2465
2020
Q3 		– Sell
-4,943
Closed -$209K – 2980
2020
Q2 		$209K Buy
+4,943
New +$160K ﹤0.01% 1810
2020
Q1 		– Sell
-15,873
Closed -$515K – 2769
2019
Q4 		$515K Sell
15,873
-8,567
-35% -$266K ﹤0.01% 1765
2019
Q3 		$636K Buy
24,440
+14,184
+138% +$475K 0.01% 1495
2019
Q2 		$376K Buy
+10,256
New +$246K ﹤0.01% 1826

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Squarepoint's ODT Position: Q1 2021 in Review

Squarepoint sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 11,168 shares — an estimated $214K sold.

Squarepoint first reported a position in ODT in Q2 2019 and held it in 5 quarters. The position peaked at $636K in Q3 2019. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

  • Squarepoint reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Squarepoint sold 11,168 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $214K.
  • Squarepoint first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2019 and held it in 5 quarters.
  • Squarepoint's Odonate Therapeutics, Inc. Common Stock position peaked at $636K in Q3 2019.
  • 83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.